Michael Kirwan Mraz, MD | |
4300 B St, Suite 200, Anchorage, AK 99503-5925 | |
(907) 375-3355 | |
(907) 375-3351 |
Full Name | Michael Kirwan Mraz |
---|---|
Gender | Male |
Speciality | Hospitalist |
Experience | 26 Years |
Location | 4300 B St, Anchorage, Alaska |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629011218 | NPI | - | NPPES |
MD48391 | Medicaid | AK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 4839 (Alaska) | Secondary |
208M00000X | Hospitalist | 4839 (Alaska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Providence Alaska Medical Center | Anchorage, AK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Alaska Hospitalist Group Llc | 6507755964 | 84 |
News Archive
A recent University of Colorado Cancer Center review in the journal Advances in Nutrition shows that rice bran offers promising cancer prevention properties. Meanwhile, an ongoing clinical trial is testing the effectiveness of rice bran in preventing the recurrence of colon cancer.
With approximately $400 million in federal stimulus dollars being funneled into local governments to develop statewide health information technology programs, states are rapidly developing Health Information Exchanges to streamline information sharing and the continuity of patient care.
Anadys Pharmaceuticals, Inc., a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C, today reported its financial results and program highlights for the second quarter ended June 30, 2010.
Researchers at the University of Colorado School of Medicine have identified a potential treatment target for patients with a common type of heart failure.
The U.S. Food and Drug Administration is warning that accidental ingestion of Tessalon (benzonatate) by children younger than 10 years can result in serious side effects or death.
› Verified 8 days ago
Entity Name | Alaska Hospitalist Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831296995 PECOS PAC ID: 6507755964 Enrollment ID: O20040312001148 |
News Archive
A recent University of Colorado Cancer Center review in the journal Advances in Nutrition shows that rice bran offers promising cancer prevention properties. Meanwhile, an ongoing clinical trial is testing the effectiveness of rice bran in preventing the recurrence of colon cancer.
With approximately $400 million in federal stimulus dollars being funneled into local governments to develop statewide health information technology programs, states are rapidly developing Health Information Exchanges to streamline information sharing and the continuity of patient care.
Anadys Pharmaceuticals, Inc., a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C, today reported its financial results and program highlights for the second quarter ended June 30, 2010.
Researchers at the University of Colorado School of Medicine have identified a potential treatment target for patients with a common type of heart failure.
The U.S. Food and Drug Administration is warning that accidental ingestion of Tessalon (benzonatate) by children younger than 10 years can result in serious side effects or death.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Michael Kirwan Mraz, MD 4300 B St, Suite 200, Anchorage, AK 99503-5925 Ph: (907) 375-3355 | Michael Kirwan Mraz, MD 4300 B St, Suite 200, Anchorage, AK 99503-5925 Ph: (907) 375-3355 |
News Archive
A recent University of Colorado Cancer Center review in the journal Advances in Nutrition shows that rice bran offers promising cancer prevention properties. Meanwhile, an ongoing clinical trial is testing the effectiveness of rice bran in preventing the recurrence of colon cancer.
With approximately $400 million in federal stimulus dollars being funneled into local governments to develop statewide health information technology programs, states are rapidly developing Health Information Exchanges to streamline information sharing and the continuity of patient care.
Anadys Pharmaceuticals, Inc., a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C, today reported its financial results and program highlights for the second quarter ended June 30, 2010.
Researchers at the University of Colorado School of Medicine have identified a potential treatment target for patients with a common type of heart failure.
The U.S. Food and Drug Administration is warning that accidental ingestion of Tessalon (benzonatate) by children younger than 10 years can result in serious side effects or death.
› Verified 8 days ago
Casey Mapes, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 | |
Stephen C Ellison, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 | |
Jonathan Daining, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 4300 B St, Suite 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 | |
Dr. Heath Wade Turner, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 | |
Alisha Alexandra Skinner, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3355 | |
Esther Lee Hargrave, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4300 B St Ste 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 | |
Larry Scott Owen, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4300 B St, Suite 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 |